Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 0.00% | 204.73 | 0.0% | $1981.02m | |
| NVAX | Novavax, Inc. | 0.00% | 110.82 | 78.2% | $792.93m | |
| BIIB | Biogen, Inc. | 0.00% | 239.30 | 1.8% | $522.63m | |
| AMGN | Amgen, Inc. | 0.00% | 235.36 | 1.4% | $522.04m | |
| BNTX | BioNTech SE | 0.00% | 196.00 | 0.0% | $501.82m | |
| GILD | Gilead Sciences, Inc. | 0.00% | 71.77 | 1.0% | $472.12m | |
| ILMN | Illumina, Inc. | 0.00% | 405.14 | 3.3% | $406.87m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.00% | 615.24 | 2.7% | $388.21m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.00% | 234.06 | 1.9% | $331.63m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 0.00% | 3.17 | 0.7% | $221.59m | |
| EXAS | EXACT Sciences Corp. | 0.00% | 78.43 | 17.9% | $151.61m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 0.00% | 148.50 | 8.2% | $151.18m | |
| ARNA | Arena Pharmaceuticals, Inc. | 0.00% | 92.65 | 13.7% | $144.29m | |
| INCY | Incyte Corp. | 0.00% | 74.88 | 2.4% | $128.10m | |
| BBIO | BridgeBio Pharma, Inc. | 0.00% | 12.75 | 0.0% | $115.66m |
Company Profile
Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.